Búsqueda | Biblioteca Virtual en Salud Odontología. Uruguay

1.

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.

McGrail, D J; Pilié, P G; Rashid, N U; Voorwerk, L; Slagter, M; Kok, M; Jonasch, E; Khasraw, M; Heimberger, A B; Lim, B; Ueno, N T; Litton, J K; Ferrarotto, R; Chang, J T; Moulder, S L; Lin, S-Y.

Ann Oncol ; 32(5): 661-672, 2021 05.

Artículo en Inglés | MEDLINE | ID: mdl-33736924

2.

Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity.

Reddy, S M; Barcenas, C H; Sinha, A K; Hsu, L; Moulder, S L; Tripathy, D; Hortobagyi, G N; Valero, V.

Br J Cancer ; 118(1): 17-23, 2018 01.

Artículo en Inglés | MEDLINE | ID: mdl-29235566

3.

Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases.

Turner, N C; Finn, R S; Martin, M; Im, S-A; DeMichele, A; Ettl, J; Diéras, V; Moulder, S; Lipatov, O; Colleoni, M; Cristofanilli, M; Lu, D R; Mori, A; Giorgetti, C; Iyer, S; Bartlett, C Huang; Gelmon, K A.

Ann Oncol ; 29(3): 669-680, 2018 03 01.

Artículo en Inglés | MEDLINE | ID: mdl-29342248

4.

Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification.

Liu, L; Toung, J M; Jassowicz, A F; Vijayaraghavan, R; Kang, H; Zhang, R; Kruglyak, K M; Huang, H J; Hinoue, T; Shen, H; Salathia, N S; Hong, D S; Naing, A; Subbiah, V; Piha-Paul, S A; Bibikova, M; Granger, G; Barnes, B; Shen, R; Gutekunst, K; Fu, S; Tsimberidou, A M; Lu, C; Eng, C; Moulder, S L; Kopetz, E S; Amaria, R N; Meric-Bernstam, F; Laird, P W; Fan, J-B; Janku, F.

Ann Oncol ; 29(6): 1445-1453, 2018 06 01.

Artículo en Inglés | MEDLINE | ID: mdl-29635542

5.

Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer.

Fujii, T; Kogawa, T; Dong, W; Sahin, A A; Moulder, S; Litton, J K; Tripathy, D; Iwamoto, T; Hunt, K K; Pusztai, L; Lim, B; Shen, Y; Ueno, N T.

Ann Oncol ; 28(10): 2420-2428, 2017 Oct 01.

Artículo en Inglés | MEDLINE | ID: mdl-28961844

6.

Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer.

Moulder, S; Helgason, T; Janku, F; Wheler, J; Moroney, J; Booser, D; Albarracin, C; Morrow, P K; Atkins, J; Koenig, K; Gilcrease, M; Kurzrock, R.

Ann Oncol ; 26(7): 1346-52, 2015 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-25878190

7.

First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors.

Hong, D S; Henary, H; Falchook, G S; Naing, A; Fu, S; Moulder, S; Wheler, J J; Tsimberidou, A; Durand, J B; Khan, R; Yang, P; Johansen, M; Newman, R A; Kurzrock, R.

Invest New Drugs ; 32(6): 1204-12, 2014 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-24919855

8.

Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer.

Falchook, G S; Moulder, S L; Wheler, J J; Jiang, Y; Bastida, C C; Kurzrock, R.

Ann Oncol ; 24(12): 3004-11, 2013 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-24158411

9.

Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience.

Wheler, J J; Tsimberidou, A M; Hong, D S; Naing, A; Falchook, G S; Fu, S; Moulder, S; Stephen, B; Wen, S; Kurzrock, R.

Ann Oncol ; 23(8): 1963-1967, 2012 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-22377564

10.

PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers.

Dumbrava, E E; Call, S G; Huang, H J; Stuckett, A L; Madwani, K; Adat, A; Hong, D S; Piha-Paul, S A; Subbiah, V; Karp, D D; Fu, S; Naing, A; Tsimberidou, A M; Moulder, S L; Koenig, K H; Barcenas, C H; Kee, B K; Fogelman, D R; Kopetz, E S; Meric-Bernstam, F; Janku, F.

ESMO Open ; 6(5): 100230, 2021 10.

Artículo en Inglés | MEDLINE | ID: mdl-34479035

11.

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.

Liedtke, C; Broglio, K; Moulder, S; Hsu, L; Kau, S-W; Symmans, W F; Albarracin, C; Meric-Bernstam, F; Woodward, W; Theriault, R L; Kiesel, L; Hortobagyi, G N; Pusztai, L; Gonzalez-Angulo, A M.

Ann Oncol ; 20(12): 1953-8, 2009 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-19596702

12.

A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline BRCA mutation demonstrates marked activity.

Litton, J K; Scoggins, M; Ramirez, D L; Murthy, R K; Whitman, G J; Hess, K R; Adrada, B E; Moulder, S L; Barcenas, C H; Valero, V; Gomez, J Schwartz; Mittendorf, E A; Thompson, A; Helgason, T; Mills, G B; Piwnica-Worms, H; Arun, B K.

NPJ Breast Cancer ; 3: 49, 2017.

Artículo en Inglés | MEDLINE | ID: mdl-29238749

13.

Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.

Moulder, S L; Yakes, F M; Muthuswamy, S K; Bianco, R; Simpson, J F; Arteaga, C L.

Cancer Res ; 61(24): 8887-95, 2001 Dec 15.

Artículo en Inglés | MEDLINE | ID: mdl-11751413

14.

A sensitive lacZ-based expression vector for analyzing transcriptional control elements in eukaryotic cells.

Spear, B T; Longley, T; Moulder, S; Wang, S L; Peterson, M L.

DNA Cell Biol ; 14(7): 635-42, 1995 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-7626223

15.

Advances in the treatment of breast cancer.

Moulder, S; Hortobagyi, G N.

Clin Pharmacol Ther ; 83(1): 26-36, 2008 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-18091763

16.

Inhibition of receptor tyrosine kinases in combination with chemotherapy for the treatment of breast cancer.

Moulder, S L; Craft, B S; Hortobagyi, G N.

Anticancer Agents Med Chem ; 8(5): 481-7, 2008 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-18537531

17.

Systemic chemotherapy for urothelial transitional cell carcinoma: an overview of toxicity.

Moulder, S L; Roth, B J.

Semin Urol Oncol ; 19(3): 194-201, 2001 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-11561987

Biblioteca Virtual en Salud Odontología. Uruguay

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: